Prescription drug · UNAPPROVED DRUG OTHER
NESTABS Prenatal Multi-vitamin/Mineral Supplement NDC 50967-219
.alpha.-tocopherol acetate, D- 30 [iU]/1 + 14 more ingredients · Tablet, Film coated · Oral · WOMENS CHOICE PHARMACEUTICALS LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50967-219-90 | 50967021990 | 1 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50967-219-90)Marketed from Feb 1, 2011 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- NESTABS Prenatal Multi-vitamin/Mineral SupplementSuffix: Prenatal Multi-vitamin/Mineral Supplement
- Generic name (nonproprietary)
- multi-vitamin/mineral supplement with sodium ascorbate, cholecalciferol, di-alpha-tocopheryl acetate, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hcl, folic acid, cyanocobalamin, calcium formate, calcium carbonate, ferrous (ii) bis-glycinate chelate, potassium iodide, zinc oxide, and choline bitartrate
- Active ingredients
- .alpha.-tocopherol acetate, D- — 30 [iU]/1Riboflavin — 3 mg/1Folic acid — 1 mg/1Niacinamide — 20 mg/1Cyanocobalamin — 10 ug/1Potassium iodide — 100 ug/1Zinc oxide — 10 mg/1Sodium ascorbate — 120 mg/1Thiamine mononitrate — 3 mg/1Cholecalciferol — 450 [iU]/1Pyridoxine hydrochloride — 50 mg/1Calcium formate — 155 mg/1Calcium carbonate — 45 mg/1Ferrous bisglycinate — 32 mg/1Choline bitartrate — 55 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Analogs/Derivatives (Chemical/Ingredient)Ascorbic Acid (Chemical structure)Calcium (Chemical structure)Calcium (Chemical structure)Divalent (Chemical structure)Divalent (Chemical structure)Decreased Copper Ion Absorption (Physiologic effect)Increased Coagulation Factor Activity (Physiologic effect)Increased Coagulation Factor Activity (Physiologic effect)Phosphate Chelating Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Vitamin B 12 (Chemical structure)Vitamin B 6 (Chemical/Ingredient)Vitamin D (Chemical structure)
- Identifiers
- Product ID 50967-219_3508d621-b5fc-6e29-e063-6294a90a9ba8SPL ID 3508d621-b5fc-6e29-e063-6294a90a9ba8SPL set ID 61945c85-3c9a-4b57-a8e1-79dd0469a042UNII A7E6112E4N, TLM2976OFR, 935E97BOY8, 25X51I8RD4, P6YC3EG204, 1C4QK22F9J, SOI2LOH54Z, S033EH8359, 8K0I04919X, 1C6V77QF41, 68Y4CF58BV, NP3JD65NPY, H0G9379FGK, SFW1D987QV, 6K2W7T9V6YUPC 0350967219909
- Pharmacologic class
- Blood Coagulation Factor; Copper Absorption Inhibitor; Phosphate Binder; Vitamin B12; Vitamin B6 Analog; Vitamin C; Vitamin D
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450967021990followed by a unit qualifier and the quantityPackage 50967-0219-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Indications and Usage: Nestabs is indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers. Nestabs is also beneficial in improving the nutritional status of women prior to conception.
Excerpt only. Read the full label for complete information.